If my patient is on warfarin, should I also give aspirin for a stroke workup?

Should You Add Aspirin to Warfarin for Stroke Workup?

No, you should not routinely add aspirin to warfarin in patients already anticoagulated for stroke prevention—the combination significantly increases bleeding risk without clear additional benefit for most indications.

Key Decision Framework

The decision depends entirely on why your patient is on warfarin:

If Warfarin is for Atrial Fibrillation:

• Do NOT add aspirin for stroke prevention alone 1, 2
• Warfarin (INR 2.0-3.0) provides protection against MI comparable to aspirin in AF patients 3
• Adding aspirin increases intracranial and extracranial hemorrhage risk without additional stroke benefit 3
• Exception: Recent coronary stenting or acute coronary syndrome requires temporary triple therapy (warfarin + aspirin + clopidogrel), but this is for coronary—not stroke—indication 1, 4, 3

If Warfarin is for Mechanical Heart Valve:

• Consider adding low-dose aspirin (75-100 mg) only if the patient has recurrent ischemic events despite therapeutic anticoagulation (INR 2.5-3.5) 2
• This is reasonable if bleeding risk is not high (no history of hemorrhage, varices, or coagulopathy) 2
• For routine valve patients without breakthrough events, warfarin alone is preferred 2

If Warfarin is for Recent MI with LV Thrombus:

• Aspirin should be added to warfarin (up to 162 mg daily, preferably enteric-coated) during the anticoagulation period 5
• This combination is specifically recommended for ischemic coronary artery disease patients 5
• Duration: at least 3 months of combined therapy 2

If Warfarin is for Cardiomyopathy/Heart Failure:

• Do NOT routinely add aspirin 2
• The benefit of warfarin itself in this population is uncertain (Class IIb evidence) 2
• Either warfarin OR antiplatelet therapy may be considered, but not both 2

Critical Bleeding Risk Considerations

The combination of warfarin plus aspirin doubles major bleeding risk 3:

• Major bleeding increases from ~1.3%/year with warfarin alone to ~2.5%/year with combination therapy
• Intracranial hemorrhage risk is particularly concerning
• Monitor closely if combination therapy is necessary 1

Common Clinical Pitfalls

1. Don't assume "more is better": Adding aspirin to therapeutic warfarin for stroke prevention in AF provides no additional benefit and causes harm 3

2. Don't confuse indications: If your patient had a stroke while on warfarin for AF, the solution is NOT to add aspirin—instead, verify therapeutic INR levels, consider switching to a DOAC, or investigate alternative stroke mechanisms 6

3. Recognize coronary vs. stroke indications: Triple therapy (warfarin + aspirin + clopidogrel) is sometimes necessary after coronary stenting in AF patients, but this is temporary (typically 1 month for bare metal stents) and driven by stent thrombosis risk, not stroke prevention 4, 3

4. Target lower INR with triple therapy: When combining warfarin with dual antiplatelet therapy post-PCI, target INR 2.0-2.5 (not 2.5-3.0) to reduce bleeding 3

Bottom Line Algorithm

For stroke workup in a patient already on warfarin:

1. Identify the indication for warfarin
2. Verify therapeutic INR levels
3. If AF or cardiomyopathy: Continue warfarin alone, do NOT add aspirin
4. If mechanical valve with breakthrough events: Consider adding aspirin 75-100 mg if low bleeding risk
5. If recent MI with LV thrombus: Add aspirin (up to 162 mg) to warfarin
6. If recent coronary stenting: Follow coronary guidelines for temporary triple therapy, then reassess

1, 2, 5, 3, 2, 3